Anticoagulation therapy versus placebo for pulmonary hypertension

  • Protocol
  • Intervention



This is the protocol for a review and there is no abstract. The objectives are as follows:

  1. To evaluate the effectiveness of and potential adverse events with the use of anticoagulation in the management of pulmonary hypertension (PH).

  2. To evaluate the effective therapeutic INR in pulmonary hypertensive patients receiving anticoagulants (North America 1.5 to 2.5, European centres 2.0 to 3.0).